E-study | Created: 01/01/2015

23andMe: The Business and Ethics of Personal Genetics Testing

This case describes the founding and growth of 23andMe, uptake of its services, questions raised by medical experts about the associations made in its tests, and regulatory issues raised in Congressional hearings and by the FDA. 

Member Content

This case is only available for viewing by members.

Please Contact Us if you are interested in becoming a member.

$3.00 Non-member price


Leave a Response

Your email address will not be published. Required fields are marked *